Belzutifan (welireg) 40 MG
Ended Awarded
- Contract number
- 36C24525N0604
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $22,051
Award facts
- Contract value 100% obligated
- $22,051.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Merck Sharp & Dohme LLC, doing business as Merck, for the delivery of the pharmaceutical drug belzutifan (Welireg) 40 mg. The award has a ceiling value of $22,051.39 and an ultimate completion date of April 28, 2025. The contract is a Delivery Order under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and utilizes Firm Fixed Price pricing. The awarding agency is the Veterans Integrated Service Network 5, a civilian agency within the Department of Veterans Affairs. This contract award is not associated with a set-aside designation. Merck is the prime contractor for this award and has held several significant Indefinite Delivery Vehicle (IDV) contracts with federal agencies, including the Centers for Disease Control and Prevention for vaccines and the National Acquisition Center for the drug Welireg.
Quick answers
Who was awarded contract 36C24525N0604?
36C24525N0604 was awarded to Merck Sharp & Dohme LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 25, 2025.
How much is contract 36C24525N0604 worth?
The government has obligated $22,051 on 36C24525N0604.
Is contract 36C24525N0604 an order under another contract?
Yes. 36C24525N0604 is a delivery order under 36F79718D0509, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0604 competed?
The extent of competition for 36C24525N0604 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award